- Lobbying
- Lobbying by Invitae Corporation
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Elizabeth Powell | Legislative Director for Rep. Jim Langevin 2001-2002 and Legislative Director/Legislative Assistant for Rep. Juanita Millender-McDonald 1997-2001 |
Katherine Collins | Deputy Director of Operations, The Executive Residence, Executive Office of the President (2011-2016) and Policy Associate, White House Cancer Moonshot Task Force, Office of the Vice President, Executive Office of the President (2016 - 2017) |
Rebecca Watts | Appropriations Director for Senator Mike DeWine (2000-2006) |
Becky Watts | Appropriations Director for Senator Mike DeWine (2000-2006) |
Vernon Dunn Jr | n/a |
Greg Kapcar | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: for health issues and pharmacogenomic testing.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate